Rev Esp Quimioter 2022;35(Suppl.1):64-66

Respiratory infections in Coronavirus disease 2019

JOSE L. DEL POZO

Published: 22 April 2022

http://www.doi.org/10.37201/req/s01.15.2022

In the last two years, the capacity of our hospitals has clearly been overwhelmed due to the COVID-19 pandemic The patient who comes to the hospital with a respiratory coinfection does not have the same characteristics as the patient who suffers a superinfection while hospitalized. The number of secondary infections increase proportionally to the severity of the patient’s disease. Besides, pathogens that cause a coinfection are clearly differentiated from the pathogens that cause a superinfection. However, in patients subjected to airway manipulation, superinfections by distinct pathogens can occur. Seventy five percent of patients admitted worldwide with COVID-19 (especially during the first two waves of the pandemic) received some form of antibiotic treatment during admission. In this context, it is essential to develop and implement algorithms that allow us to define the predictors in each individual case for the development of a superinfection.

Rev Esp Quimioter 2022; 35(Suppl. 1):64-66 [Full-text PDF]